Failure to Diagnose Prostate Cancer FAQs

A failure to diagnose prostate cancer can occur for many different reasons. Physicians may overlook elevated PSA test results, fail to investigate abnormal findings during a digital rectal examination, or neglect to recommend additional diagnostic testing despite persistent symptoms. In other situations, patients are not referred to a urologist when specialist evaluation is appropriate, or suspicious imaging or biopsy findings are improperly interpreted. Laboratory or pathology errors can also contribute to delayed diagnoses. Although no screening method guarantees detection, healthcare providers are expected to recognize when additional evaluation is medically necessary based on the patient's history, symptoms, risk factors, and clinical findings.

Determining whether a delayed diagnosis resulted from malpractice requires much more than showing that cancer was eventually discovered. Under New York law, patients generally must prove that a healthcare provider failed to provide treatment consistent with accepted medical standards and that the delay caused additional harm. Attorneys and medical experts often review office records, laboratory reports, imaging studies, pathology findings, and referral histories to determine whether another reasonably competent physician would have diagnosed the cancer sooner. If earlier testing or treatment would likely have improved the patient's outcome, the patient may be able to pursue a medical malpractice claim.

The consequences of a delayed prostate cancer diagnosis often become more serious as the disease progresses. Cancer identified during its early stages may sometimes be treated with surgery, radiation therapy, or carefully monitored active surveillance. As the disease advances beyond the prostate, however, treatment options frequently become more aggressive and may include hormone therapy, chemotherapy, or other systemic treatments. Delayed diagnosis may also increase the likelihood that cancer spreads to nearby tissues or distant organs, reducing survival rates and creating additional physical and emotional burdens for patients and their families.

Compensation in a delayed prostate cancer case is intended to address both the financial and intangible losses of negligent medical care. Under New York law, patients may recover economic damages for medical bills, surgeries, medications, radiation therapy, hospitalizations, rehabilitation, future healthcare needs, lost income, and diminished earning capacity. They may also pursue non-economic damages for pain and suffering, emotional distress, physical impairment, and the loss of enjoyment of life associated with more advanced disease and invasive treatment. When a delayed diagnosis results in a patient's death, surviving family members may also have legal remedies under New York's wrongful death laws.

The deadline for filing a prostate cancer malpractice lawsuit depends on several factors. In most cases, New York requires medical malpractice actions to be commenced within two years and six months from the date of the malpractice or the conclusion of continuous treatment for the same condition. Certain delayed cancer diagnosis claims may qualify for New York's limited discovery rule, which can affect when the statute of limitations begins to run. Because calculating these deadlines can be complicated, particularly when multiple healthcare providers are involved, patients should consult an attorney promptly to preserve both their legal rights and important medical evidence.